News

    Red Glead Discovery is hosting Öresund Peptide Symposium

    Jul 3, 2023

    Facilitating knowledge exchange and networking for experts in peptide science The Öresund Peptide Symposium is held for the fourth time since its start. The program for this year will bring together industry leaders and researchers within peptide drug discovery and green peptide...

    Read More

    Red Glead Discovery receives Lund municipality’s business award 2023

    Apr 14, 2023

    The award is given annually to a company in Lund that is working with global challenges of the future, that is innovative and that is recognised as a good ambassador for the municipality.   “We are incredibly grateful for...

    Read More

    Aqilion secures strategic research alliance with Merck worth up to EUR 950 million for their TAK1 kinase inhibitor program

    Feb 23, 2023

    We are delighted to share the news of the recent success of Aqilion, who secured an exclusive license and strategic research collaboration with Merck. The deal is worth up to EUR 950 million for their pre-clinical TAK1 inhibitor program....

    Read More

    For the 5th time, Team Red Glead receives the DI Gasell award – an annual recognition of the fastest growing companies in Sweden

    Nov 8, 2022

    Five times during the last six years, Red Glead Discovery AB has been recognized as a Gasell company by Scandinavia’s largest business paper, Dagens Industri. The award is given annually to fast-growing and profitable Swedish companies with sound finances...

    Read More

    MSc thesis at Red Glead Discovery/Lund University provided new insights for the treatment of drug-resistant malaria

    Oct 24, 2022

    Evaluation of gold-based compounds as Plasmodium falciparum aquaglyceroporin inhibitors An extensive cross-disciplinary study involving computational chemistry, synthesis and in vitro testing returned promising insights on the application of metal complexes for the treatment of drug-resistant malaria. During the investigation,...

    Read More

    Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement

    Aug 30, 2022

      Lund, Sweden August 30th, 2022   Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement.   Red Glead Discovery has now...

    Read More

    Desupervised and Red Glead Discovery receive Eurostars R&D grant to deliver AId- a novel artificial intelligence-based tool for Drug Discovery

    Feb 22, 2022

    Copenhagen, Denmark and Lund, Sweden February 22nd, 2022   In this unique strategic partnership, Desupervised and Red Glead Discovery join forces to create robust AI-based solutions enabling companies to reduce cost and time in small molecule drug research and...

    Read More

    Head of Science appointed Adjunct Professor in Organic Chemistry with a green focus

    Dec 17, 2021

    Our co-worker Johan Wennerberg has been appointed Adjunct Professor in Organic Chemistry with a focus on green process development at The Faculty of Engineering, LTH, Lund University. In his new role, Johan will contribute to more interactions between academia...

    Read More

    Red Glead Discovery appoints new CFO

    Dec 10, 2021

    Red Glead Discovery AB have appointed Ann Helen Forsling as CFO to strengthen the capacity of its executive management team. Forsling have previously worked at BLS industries as a CFO for the last three years and prior to that...

    Read More

    Gazelle 2021, for the fourth time in five years!

    Nov 17, 2021

    Red Glead Discovery has been recognized as a Gazelle 2021 for the fourth time in five years! Less than 1% of Swedish companies qualify for this “fast-growth-award”. Another great recognition for the fantastic work performed by our engaged co-workers.

    Read More